Stafford Kristin - Jun 5, 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Director
Signature
Ovie Onobrakpeya, as attorney in fact for Stafford, Kristin
Stock symbol
NVCR
Transactions as of
Jun 5, 2023
Transactions value $
$0
Form type
4
Date filed
6/6/2024, 05:43 PM
Previous filing
May 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Award $0 +4.05K $0.00 4.05K Jun 5, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Stock Option (Right to Buy) Award $0 +6.23K $0.00 6.23K Jun 5, 2024 Ordinary Shares 6.23K $23.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
F2 Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.